EBS News and Press, Emergent Biosolutions Inc. From 07/15/21

GAITHERSBURG, Md., July 15, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 29, 2021 at 5:00 pm eastern time to discuss the financial results for the second quarter of 2021, recent business developments, revenue guidance for the ...

Tasos Katopodis/Getty Images News Emergent BioSolutions ([[EBS]] +1.1%) has gained in morning hours after the company announced that a government agency exercised an option to extend a contract term related to its supply of Smallpox vaccine into the U.S. Strategic National Stockpile...

They say that any publicity is good publicity. Emergent BioSolutions (NYSE: EBS) might disagree after its highly publicized COVID-19 vaccine manufacturing problems. In this Motley Fool Live video recorded on June 23 , Motley Fool contributors Keith Speights and Brian Or...

Scott Olson/Getty Images News The FDA has greenlighted another set of COVID-19 vaccine doses made for Johnson & Johnson ([[JNJ]] +1.7%) by the contract manufacturer Emergent BioSolutions ([[EBS]] +0.3%) at the company’s Baltimore manufacturing facility, Bloomberg reported. The...

New York, New York--(Newsfile Corp. - June 23, 2021) - Faruqi & Faruqi, LLP, a leading minority and Woman-owned national securities law firm, is investigating potential misconduct at Emergent BioSolutions Inc. ("Emergent BioSolutions" or the "Company") (NYSE: EBS). The investigation focus...

The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent”) on behalf investors who purchased or acquired Emergent common ...

SAN FRANCISCO, CA / ACCESSWIRE / June 16, 2021 / Hagens Berman urges Emergent BioSolutions Inc. (NYSE:EBS) investors with $100k or more losses to submit your losses now . Class Period: Apr. 24, 2020 - Apr. 16, 2021 Lead Plaintiff Deadline: June 18, 2021 Visit: www.hbsslaw.com/in...

Tasos Katopodis/Getty Images News The FDA has given the OK for Johnson & Johnson (JNJ) to distribute another 14M doses of its COVID-19 vaccine produced at an Emergent BioSolutions (EBS) Baltimore facility, Reuters reported. Nearly all of the doses that have been authorized to date are exp...

San Francisco, California--(Newsfile Corp. - June 15, 2021) -   Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now . Class Period: Apr. 24, 2020 - Apr. 16, 2021 Lead Plaintiff Deadline: June 18, 2021 Visit: ...

Emergent continues to work with the FDA to address identified observations at Bayview facility in order to release additional batches and resume production GAITHERSBURG, Md., June 11, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that two batch...